Felix Hoffmann, Wilhelm Roehl, Hans Andersag and Walter Kikuth, Gerhard Domagk, Otto Bayer, Friedrich Bossert, Wulf Vater – researchers and scientists who made history. They were responsible for pioneering inventions that revolutionized medicine, chemistry and materials development: Aspirin™, Germanin™, Resochin™, sulfonamides and Adalat™.
These outstanding scientists all had one thing in common: they established Bayer's reputation as an innovation company. Bayer retains a strong commitment to this tradition. The Group’s realignment enables us to focus on areas where innovation is the driving force: health care, nutrition and high-tech materials.
Innovation plays a major role in addressing the global challenges of providing health care and nutrition for the world’s growing population and conserving dwindling resources. It is a key driver of future growth at Bayer.
Learn more about the innovation company on a journey through the world of research in our scientific magazine research.
The success of our company is based on excellence in research and development (R&D). The know-how and skills of our employees are our most valuable resource in this endeavor. We develop new molecules and technologies in the research-intensive fields of medicine and modern agriculture and invest continuously in research and development projects.
We maintain a global network of research and development locations, where more than 15,100 scientists are employed. In 2020, we increased our research and development investment by 17.2 percent (Fx adj.) to €7,126 million.
Focus on Innovation
Innovation is a cornerstone of our mission “Science For A Better Life” and a core element of our strategy. We define innovations as new solutions that generate added value for our customers and society. Our activities focus on innovative products based on our strong research and development competencies. They are accompanied by process, service and business model innovation.
With our innovative solutions, we are responding to the global challenges in medical care and the need to safeguard an adequate food supply. Here we focus on three key elements: excellence in research and development, the application of groundbreaking technologies, and open innovation.
Portraits of Four Bayer Researchers
Andre Puetz is a biotechnologist and constantly searching for new biocatalysts for Bayer. In nature, these substances allow the formation of chemical compounds, which can only be produced very laboriously using state-of-the-art technology. This opens up new possibilities for the development and production of new active ingredients for medicines and crop protection products.
Proteins are the building blocks of life. Jan Tebbe and his colleagues at Bayer have the task of tailoring such proteins for the development of new drugs and the protection of plants. For this they use biotechnology. In this video, Jan Tebbe talks about the challenges they are facing.
Frank Berendes has always been fascinated by biology. In his job in biological production at Bayer, he can use his knowledge of microorganisms to help produce valuable drugs and biological crop protection products.
Anyone who talks to researcher Horst Antonicek quickly realizes that biochemistry is very important to him. At Bayer, he uses high-tech robots to search for substances that may protect plants. And more recently, he has been sharing knowledge with colleagues who are searching for active ingredients for drugs.